Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Panacea Biotec Ltd.
₹338.80
₹336.00
₹349.35
₹281.10
₹581.90
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 99.31 | 90.81 | 112.25 | 67.90 | 108.43 |
| Operating Expense | 100.69 | 104.51 | 115.27 | 86.47 | 93.04 |
| Operating Profit | -1.38 | -13.70 | -3.02 | -18.57 | 15.39 |
| Depreciation | 4.89 | 4.91 | 4.77 | 4.91 | 5.21 |
| Interest | 7.04 | 5.93 | 6 | 4.64 | 3.85 |
| Tax | -2.11 | -5.29 | -2.14 | -9.64 | 0 |
| Net Profit | -7.36 | -15.64 | -6.70 | -12.39 | 9.65 |
₹338.80
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 72.9 | 72.5 | 72.5 | 72.5 | 72.5 | 72.5 |
| FII | 0.4 | 0.4 | 1.2 | 0.8 | 1.1 | 1.4 |
| DII | 1.1 | 1.1 | 1.4 | 1.5 | 1.8 | 1.8 |
| Public | 25.6 | 26 | 24.9 | 25.2 | 24.6 | 24.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 22.33 K | 50.4 K | 44.31% |
| Week | 34.98 K | 85.71 K | 40.81% |
| 1 Month | 48.65 K | 1.24 L | 39.21% |
| 6 Month | 1.16 L | 7.02 L | 16.51% |
Consistent high performing stocks over Five Years
Turnaround Companies: Loss to Profit QoQ
Expensive Performers (DVM)
PEG lower than Industry PEG
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2011 | 0.75 | FINAL | Equity Share | |
| 16 Sep, 2010 | 0.25 | FINAL | Equity Share | |
| 19 Sep, 2008 | 1 | FINAL | Equity Share | |
| 21 Sep, 2007 | 1 | FINAL | Equity Share | |
| 22 Sep, 2006 | 1 | FINAL | Equity Share | |
| 12 Aug, 2005 | 1.5 | FINAL | Equity Share | |
| 13 Sep, 2004 | 1 | FINAL | Equity Share | |
| 12 Sep, 2003 | 1 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹8.43 | ₹104 | ₹115.35 | ₹604 | ₹791.10 | ₹690 |
| % Change | 4.98% | -1.38% | -3.98% | -1.99% | -2.37% | 3.06% |
| Revenue TTM (₹ Cr) | ₹104.12 | ₹282.74 | - | ₹488.20 | ₹588.52 | ₹1,496.96 |
| Net Profit TTM (₹ Cr) | ₹-24.37 | ₹15.30 | - | ₹56.90 | ₹101.60 | ₹132.41 |
| PE TTM | -2.90 | 26.50 | - | 30.70 | 36.00 | 29.60 |
| 1 Year Return | 743 | -17.19 | 27.77 | 0.89 | 41.16 | -12.8 |
| ROCE | -5.63 | - | - | 23.87 | 9.34 | 14.12 |
Valiant Laboratories Ltd.
₹ 59.10
+1.37%
Sigachi Industries Ltd.
₹ 21.22
-3.68%
Windlas Biotech Ltd.
₹ 774.00
-0.82%
Vineet Laboratories Ltd.
₹ 31.51
-1.62%
Solara Active Pharma Sciences Ltd.
₹ 472.60
+0.23%
Zim Laboratories Ltd.
₹ 72.00
+1.72%
Medico Remedies Ltd.
₹ 48.00
+4.53%
Dishman Carbogen Amcis Ltd.
₹ 182.40
+0.07%
Lasa Supergenerics Ltd.
₹ 8.05
+2.42%
Advanced Enzyme Technologies Ltd.
₹ 313.00
+0.02%
Bajaj Healthcare Ltd.
₹ 348.00
-1.29%
Ortin Global Ltd.
₹ 18.91
-4.97%
Brooks Laboratories Ltd.
₹ 72.62
-2.48%
RPG Life Sciences Ltd.
₹ 1915.00
+0.59%
Bafna Pharmaceuticals Ltd.
₹ 111.50
-1.11%
Alpa Laboratories Ltd.
₹ 68.45
+2.30%
Sun Pharma Advanced Research Company Ltd.
₹ 127.75
-1.13%
SMS Pharmaceuticals Ltd.
₹ 375.20
+0.74%
Nectar Lifesciences Ltd.
₹ 12.70
+0.63%
Mangalam Drugs and Organics Ltd.
₹ 31.15
-1.61%
Indoco Remedies Ltd.
₹ 200.10
+0.93%
Ind-Swift Laboratories Ltd.
₹ 146.60
+3.32%
Lincoln Pharmaceuticals Ltd.
₹ 619.00
-0.58%
By signing up I certify terms, conditions & privacy policy